1. Home
  2. SAGE vs SKYH Comparison

SAGE vs SKYH Comparison

Compare SAGE & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • SKYH
  • Stock Information
  • Founded
  • SAGE 2010
  • SKYH 2017
  • Country
  • SAGE United States
  • SKYH United States
  • Employees
  • SAGE N/A
  • SKYH N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • SKYH Military/Government/Technical
  • Sector
  • SAGE Health Care
  • SKYH Industrials
  • Exchange
  • SAGE Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • SAGE 413.9M
  • SKYH 367.5M
  • IPO Year
  • SAGE 2014
  • SKYH N/A
  • Fundamental
  • Price
  • SAGE $9.30
  • SKYH $9.65
  • Analyst Decision
  • SAGE Hold
  • SKYH Strong Buy
  • Analyst Count
  • SAGE 18
  • SKYH 3
  • Target Price
  • SAGE $10.06
  • SKYH $14.83
  • AVG Volume (30 Days)
  • SAGE 2.4M
  • SKYH 158.9K
  • Earning Date
  • SAGE 07-30-2025
  • SKYH 08-12-2025
  • Dividend Yield
  • SAGE N/A
  • SKYH N/A
  • EPS Growth
  • SAGE N/A
  • SKYH N/A
  • EPS
  • SAGE N/A
  • SKYH N/A
  • Revenue
  • SAGE $47,404,000.00
  • SKYH $17,950,000.00
  • Revenue This Year
  • SAGE $102.21
  • SKYH $122.85
  • Revenue Next Year
  • SAGE $43.01
  • SKYH $45.30
  • P/E Ratio
  • SAGE N/A
  • SKYH N/A
  • Revenue Growth
  • SAGE N/A
  • SKYH 102.32
  • 52 Week Low
  • SAGE $4.62
  • SKYH $8.26
  • 52 Week High
  • SAGE $13.47
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 78.92
  • SKYH 35.81
  • Support Level
  • SAGE $6.44
  • SKYH $9.60
  • Resistance Level
  • SAGE $9.33
  • SKYH $10.02
  • Average True Range (ATR)
  • SAGE 0.26
  • SKYH 0.36
  • MACD
  • SAGE 0.33
  • SKYH -0.00
  • Stochastic Oscillator
  • SAGE 98.98
  • SKYH 5.75

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: